Barrett's esophagus and the costs of "doing something"

Gastrointestinal Endoscopy

Volumn 65, Issue 1, 2007, Pages 31-35

  Dellon, Evan S ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; PRECANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BREAST NEOPLASMS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; POPULATION SURVEILLANCE; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 33845502312     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.07.015     Document Type: Editorial

References (40)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
3. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
4. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
5. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
6. Falk G.W., Ours T.M., and Richter J.E. Practice patterns for surveillance of Barrett's esophagus in the united states. Gastrointest Endosc 52 (2000) 197-203
7. Shaheen N.J., Provenzale D., and Sandler R.S. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Am J Gastroenterol 97 (2002) 1319-1327
8. Dellon E.S., and Shaheen N.J. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?. J Clin Oncol 23 (2005) 4478-4482
9. Gerson L.B., Ullah N., Hastie T., et al. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?. Gastrointest Endosc 65 (2007) 16-25
10. Gerson L.B., Ullah N., Hastie T., et al. Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol 100 (2005) 524-533
11. Eloubeidi M.A., and Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 95 (2000) 1881-1887
12. Fisher D., Jeffreys A., Bosworth H., et al. Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol 97 (2002) 2193-2200
13. Kruijshaar M.E., Siersema P.D., Janssens A.C.J.W., et al. Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest Endosc 65 (2007) 26-30
14. Shaheen N.J., Green B., Medapalli R.K., et al. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology 129 (2005) 429-436
15. Schwartz L.M., Woloshin S., Fowler Jr. F.J., et al. Enthusiasm for cancer screening in the United States. JAMA 291 (2004) 71-78
16. Jacowitz K.E., and Kahneman D. Measures of anchoring in estimation tasks. Pers Soc Psychol Bull 21 (1995) 1161-1167
17. Woloshin S., Schwartz L.M., Byram S., et al. A new scale for assessing perceptions of chance: a validation study. Med Decis Making 20 (2000) 298-307
18. Woloshin S., and Schwartz L.M. Reducing the risk that patients get it wrong. Gastroenterology 129 (2005) 748-750
19. Shaheen N.J., Dulai G.S., Ascher B., et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 100 (2005) 577-580
20. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
21. Eckardt V.F., Kanzler G., and Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 111 (2001) 33-37
22. Anderson L.A., Murray L.J., Murphy S.J., et al. Mortality in Barrett's oesophagus: results from a population based study. Gut 52 (2003) 1081-1084
23. Macrae F.A., Hill D.J., St John D.J., et al. Predicting colon cancer screening behavior from health beliefs. Prev Med 13 (1984) 115-126
24. Zacks S., Beavers K., Theodore D., et al. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 40 (2006) 220-224
25. Castera L., Constant A., Bernard P.H., et al. Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases. World J Gastroenterol 12 (2006) 1545-1550
26. Frijling B.D., Lobo C.M., Keus I.M., et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns 52 (2004) 47-53
27. Dolan N.C., Lee A.M., and McDermott M.M. Age-related differences in breast carcinoma knowledge, beliefs, and perceived risk among women visiting an academic general medicine practice. Cancer 80 (1997) 413-420
28. Black W.C., Nease Jr. R.F., and Tosteson A.N. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87 (1995) 720-731
29. Erblich J., Bovbjerg D.H., Norman C., et al. It won't happen to me: lower perception of heart disease risk among women with family histories of breast cancer. Prev Med 31 (2000) 714-721
30. Metcalfe K.A., and Narod S.A. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 94 (2002) 1564-1569
31. Vernon S.W., Vogel V.G., Halabi S., et al. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat 28 (1993) 137-144
32. Sutton S., Bickler G., Sancho-Aldridge J., et al. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Commun Health 48 (1994) 65-73
33. McCaul K.D., Branstetter A.D., Schroeder D.M., et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol 15 (1996) 423-429
34. Hailey B.J., Carter C.L., and Burnett D.R. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care Women Int 21 (2000) 701-715
35. Gross C.P., Filardo G., Singh H.S., et al. The relation between projected breast cancer risk, perceived cancer risk, and mammography use: results from the National Health Interview Survey. J Gen Intern Med 21 (2006) 158-164
36. Lipkus I.M., Iden D., Terrenoire J., et al. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 533-539
37. Jacobsen P.B., Valdimarsdottier H.B., Brown K.L., et al. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59 (1997) 459-466
38. Stefanek M.E., Helzlsouer K.J., Wilcox P.M., et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 24 (1995) 412-419
39. van Dooren S., Rijnsburger A.J., Seynaeve C., et al. Psychological distress in women at increased risk for breast cancer: the role of risk perception. Eur J Cancer 40 (2004) 2056-2063
40. Katapodi M.C., Lee K.A., Facione N.C., et al. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38 (2004) 388-402